Literature DB >> 6991972

Iopamidol, a new non-ionic hydrosoluble contrast medium for neuroradiology.

B Hammer, W Lackner.   

Abstract

The side effects associated with the use of Iopamidol for myelography were determined in 100 patients and compared with metrizamide in a double-blind study.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6991972     DOI: 10.1007/bf00342385

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  6 in total

1.  [Late meningeal changes due to water-soluble myelographic contrast medium (author's transl)].

Authors:  B Hammer
Journal:  Rofo       Date:  1977-02

2.  Results of a double blind study of three contrast media and technic for lumbosacral radiculography.

Authors:  B Hammer
Journal:  Neuroradiology       Date:  1978-11-24       Impact factor: 2.804

3.  [Left ventriculography and coronary angiography with a new non-ionic contrast medium. Hemodynamic, metabolic and electrocardiographic study in comparison with a commonly used contrast medium (author's transl)].

Authors:  F Cucchini; M Di Donato; G Baldi; F N Effendy; S Bongrani; B Colla; O Visioli
Journal:  G Ital Cardiol       Date:  1979

4.  Advantages of a new non ionic contrast medium. The results of animal experiments.

Authors:  A Belán; K Benda; J Fabián; J Bláha
Journal:  Ann Radiol (Paris)       Date:  1978 May-Jun

5.  Radiopaque contrast media. XLIV - Preclinical studies with a new nonionic contrast agent.

Authors:  E Felder; D Pitrè; P Tirone
Journal:  Farmaco Sci       Date:  1977-11

6.  Amipaque myelography without late adhesive arachnoid changes.

Authors:  P Ahlgren
Journal:  Neuroradiology       Date:  1978-02-17       Impact factor: 2.804

  6 in total
  15 in total

1.  Iopamidol-induced meningoencephalopathy in an HIV-seropositive patient.

Authors:  Jeffrey S Stroup; Johnny R Stephens; Damon L Baker
Journal:  Proc (Bayl Univ Med Cent)       Date:  2007-01

2.  Large volume full columnar lumbar myelography.

Authors:  J R Jinkins
Journal:  Neuroradiology       Date:  1987       Impact factor: 2.804

3.  Electrophysiological and cognitive effects of lumbar myelography with iopamidol: comparison with diagnostic lumbar puncture.

Authors:  L Provinciali; M G Ceravolo; M Signorino; M Baroni; U Pasquini; R Cerrutti; U Salvolini
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

4.  Radiculography with reduced amounts of contrast medium.

Authors:  E Signorini; N Caputo; C Chiurulla; E Ciorba; G P Pelliccioli; E Cianciulli
Journal:  Acta Neurochir (Wien)       Date:  1984       Impact factor: 2.216

5.  Adverse side effects of metrizamide and iopamidolo in myelography.

Authors:  A Carella; F Federico; F Di Cuonzo; E Vinjau; P Lamberti
Journal:  Neuroradiology       Date:  1982       Impact factor: 2.804

6.  Experiences with intrathecally enhanced computed tomography.

Authors:  B Hammer
Journal:  Neuroradiology       Date:  1980       Impact factor: 2.804

7.  Urinary excretion of Iopamidol following intrathecal administration.

Authors:  D Pitrè; M F Zingales; C Trevisan
Journal:  Neuroradiology       Date:  1983       Impact factor: 2.804

8.  Psychopathometric demonstration and quantification of mental disturbances following myelography with metrizamide and iopamidol.

Authors:  G Galle; W Huk; K Arnold
Journal:  Neuroradiology       Date:  1984       Impact factor: 2.804

9.  Rate of clearance of intrathecal iopamidol in the dog.

Authors:  J Wilcox; C A Evill; M R Sage
Journal:  Neuroradiology       Date:  1986       Impact factor: 2.804

10.  Iotrol, a new water-soluble non-ionic dimeric contrast medium for intrathecal use.

Authors:  B Hammer; E Deisenhammer
Journal:  Neuroradiology       Date:  1985       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.